Recurrent Melanoma Completed Phase 3 Trials for Melphalan (DB01042)

Also known as: Melanoma Recurrent

IndicationStatusPhase
DBCOND0028662 (Recurrent Melanoma)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00003789Melphalan With or Without Tumor Necrosis Factor in Treating Patients With Locally Advanced Melanoma of the Arm or LegTreatment